Navigation Links
Towards a real understanding of depression
Date:10/23/2013

New York, New YorkThe Neuropsychoanalysis Association (NPSA) is hosting a conference for researchers and clinicians on depression, "Towards a Real Understanding of Depression: Lessons from the Treatment Battlefeld and New Research," on Friday, November 1, 2013 from 9:00 am to 6:00 pm at the Icahn School of Medicine at Mount Sinai, The Bonnie and Kenneth Davis Auditorium, 1470 Madison Avenue (between 101st and 102nd Streets) in New York City. Recent meta-analyses have indicated that SSRIs, although extremely effective for some, have not fulfilled their original promise of being a broadly successful anti-depressant. This full day program will be an interdisciplinary event focusing on pioneering work in biological psychiatry, basic neuroscience and other fields aimed at discovering new treatments for depression, including what have we learned so far, future directions; and how to use the data from new treatment research to hone in on the core pathophysiology of depression and models of brain organization which underlie approaches to treatment.

Featured keynote speakers include Steven Paul (Cornell), "Why we need new and better antidepressants: lessons from the treatment and clinical research battlefield;" and Jaak Panksepp (Washington State University), "Pre-clinical affective neuroscience modelling of depression, and evaluation of three new antidepressant strategies."

WHAT: Towards a Real Understanding of Depression: Lessons from the Treatment Battlefield and New Research

WHEN: Friday, November 1, 2013
9:00 am 6:00 pm

WHERE: Icahn School of Medicine at Mount Sinai, Bonnie and Kenneth Davis Auditorium
1470 Madison Avenue (between 101st and 102nd Streets), NYC

REGISTRATION: Addavail Coslett, Associate Dir. Programming & Development acoslett@npsafoundation.org or 212-572-3693

PROGRAM SPEAKERS:

Maggie Zellner, The Neuropsychoanalysis Foundation

Ronald Duman (Yale), Neurobiology of stress, depression and antidepressants: Remodeling synaptic connections

James Murrough (Mt Sinai), Ketamine as a fast-acting antidepressant

Elizabeth Fitelson (Columbia), Estrogen and other hormones in depression

Dan Javitt, (Columbia), Depression from a glutamatergic perspective: the interaction of neuromodulation and brain glutamatergic systems

Wayne Goodman (Mt. Sinai), DBS treatment for depression

Dan Iosifescu (Mt. Sinai School of Medicine), Non-invasive neurostimulation for the treatment of major depression

Cori Bargmann (Rockefeller), The BRAIN Initiative: Understanding brain circuits as a foundation for accelerating human neuroscience

Baruch Fishman (New York-Presbyterian/Weill Cornell), CBT perspectives on depression and treatment

Mark Solms (University of Cape Town), Psychoanalytic perspectives on depression and the panic-shutdown hypothesis

Andrew Gerber (Columbia), Empirical outcome studies of psychodynamic and cognitive behavioral therapies, and brain effects of treatment


'/>"/>

Contact: Jane E. Rubinstein
jrubinstein@rubenstein.com
212-843-8287
Neuropsychoanalysis Foundation
Source:Eurekalert

Related biology news :

1. Nitrogen fertilizer remains in soils and leaks towards groundwater for decades, researchers find
2. The large-scale EU project EU BON: Towards integration with its global counterpart GEO BON
3. Towards more sustainable construction
4. Report: Water and Agriculture in Canada: Towards Sustainable Management of Water Resources
5. BESAFE Conference in Manchester: Working towards a brighter future for biodiversity
6. Towards a new moth perfume
7. EU BON: Working towards integrated and comprehensive global biodiversity data
8. University of Alberta research working towards treatment for aortic aneurysms in the abdomen
9. Plastic packaging industry is moving towards completely bio-based products
10. Towards computing with water droplets -- superhydrophobic droplet logic
11. Zebra fish point the way towards new therapies for amyotrophic lateral sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2020)... CHURCH, Va. (PRWEB) , ... July 08, 2020 ... ... The Latest on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July ... may need a comparability study, but what is the most effective way to ...
(Date:7/4/2020)... ... July 03, 2020 , ... ... outstanding recognition and multiple awards for not only the products and treatments developed, ... Skincare and Vivace® Microneedle RF. All the brands built by ABM have received ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... has announced a publication detailing the use of its revolutionary NEXTGENPCR endpoint ... reaction (RT-PCR) in 16 minutes. The article, titled "Ultra-fast one-step RT-PCR protocol ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... The SDX® Respiratory Gating ... countries, has reached its 20th anniversary of worldwide use. Introduced in the US ... universities including University of Pennsylvania, University of Michigan, University of Maryland, University of ...
(Date:7/18/2020)... MILWAUKEE (PRWEB) , ... July 16, 2020 , ... “We ... at Third Wave Bioactives. “It’s the only technology of its kind on the market ... flavor of onions with the protective capacity of traditional cultured ingredients, creating a natural ...
(Date:7/10/2020)... (PRWEB) , ... July 09, ... ... biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has expanded ... broader license allows PathSensors to move into the point-of-care diagnostic market, focusing ...
(Date:7/7/2020)... (PRWEB) , ... July 06, 2020 , ... ... Practices Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, ... 2003, Bio-IT World has hosted an elite awards program, highlighting outstanding examples of ...
Breaking Biology Technology: